BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17941930)

  • 1. New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
    Shariat SF; Karam JA; Margulis V; Karakiewicz PI
    BJU Int; 2008 Mar; 101(6):675-83. PubMed ID: 17941930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.
    Shariat SF; Scherr DS; Gupta A; Bianco FJ; Karakiewicz PI; Zeltser IS; Samadi DB; Akhavan A
    Arch Esp Urol; 2011 Oct; 64(8):681-94. PubMed ID: 22052751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
    Bickers B; Aukim-Hastie C
    Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers for prostate cancer in predicting diagnosis, staging and prognosis].
    Ohori M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):6-10. PubMed ID: 19151558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers for prostate cancer: a rational approach to the literature.
    Steuber T; O'Brien MF; Lilja H
    Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other biomarkers for detecting prostate cancer.
    Nogueira L; Corradi R; Eastham JA
    BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P; Wolff JM; Mattelaer P; Jakse G
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for prostate cancer.
    Leman ES; Getzenberg RH
    J Cell Biochem; 2009 Sep; 108(1):3-9. PubMed ID: 19507229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for prostate cancer detection.
    Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
    J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
    Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen.
    Fradet Y
    Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodborne biomolecular markers in prostate cancer development and progression.
    Bok RA; Small EJ
    Nat Rev Cancer; 2002 Dec; 2(12):918-26. PubMed ID: 12459730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis in stage a prostate cancer].
    Murase T; Kuriyama M; Maeda S; Ando Y; Itoh H; Watanabe H
    Hinyokika Kiyo; 1996 Sep; 42(9):639-43. PubMed ID: 8918661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels].
    Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K
    Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.